Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients

BACKGROUND: Glucose tolerance abnormalities including cystic fibrosis related diabetes (CFRD) are common in patients with cystic fibrosis (CF). The underlying pathophysiology is not fully understood. Emerging evidence suggests that CFTR dysfunction may directly or indirectly impact β-cell function,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cyst Fibros
Main Authors: Moheet, Amir, Beisang, Daniel, Zhang, Lin, Sagel, Scott D., VanDalfsen, Jill M., Heltshe, Sonya L., Frederick, Carla, Mann, Michelle, Antos, Nicholas, Billings, Joanne, Rowe, Steven M., Moran, Antoinette
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7937760/
https://ncbi.nlm.nih.gov/pubmed/32917547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2020.09.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados